Transparency Market Research in its new report titled, “Ophthalmic Anti-infective Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2026,” provides key insights on the ophthalmic anti-infective market. The TMR report anticipates that the increased incidence rate of eye diseases, such as, uveitis, conjunctivitis, dry eye, etc. across the world will drive the ophthalmic anti-infective market during the forecast period i.e, 2018-2026. Also, the large base of patients suffering from eye diseases globally is driving the global market for ophthalmic anti-infective. With the increase of patient pool across the globe, major market players are increasing R&D investments to capture high share in the market. However, patent expiration and lack of awareness about eye disorders/diseases in underdeveloped countries are some of the key restraints for the global ophthalmic anti-infective market. Moreover, absence of health insurance facilities in several developing countries is another factor hindering the global ophthalmic anti-infective market, says the report.
The TMR report has segmented the global ophthalmic anti-infective market based on type of infection, type of formulation, type of product, distribution channel, and region. Based on type of infection, the ophthalmic anti-infective market is classified into antibacterial, antiviral, antifungal, anti-parasitic, and others. Based on type of formulation, the ophthalmic anti-infective market can be categorized into solutions, suspensions, ointments, and others. According to type of product, the market is segmented into prescription drugs and over-the-counter drugs. In terms of distribution channel, the ophthalmic anti-infective market is divided into hospital pharmacies, retail pharmacies, and online pharmacies.
On the basis of geographical stand, the global ophthalmic anti-infective market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Among these, North America is expected to dominate the global ophthalmic anti-infective market due to availability of advanced drug formulations in the region. Awareness among people about diseases is also a major factor boosting the market in the region. The ophthalmic anti-infective market in Asia Pacific is anticipated to expand at a rapid pace due to increase in incidence of eye infection in the region. Lack of awareness about diseases and unavailability of advanced medication and formulations in underdeveloped countries, such as Lebanon, Syria, Cyprus, Turkey, and Iraq are likely to restrain the growth of the ophthalmic anti-infective market in Middle East & Africa. Some of the major players operating in the global market of ophthalmic anti-infective are profiled in this report to give a better competitive analysis of the market and these include Aerie Pharmaceuticals, ALLERGAN, Valeant, Bayer AG, Genentech, Inc., Novartis AG, Pfizer Inc., among others.
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453